Vaccine Study

Single Dose Of Covishield 61% Effective; Will Revisit Vaccine Interval With Fresh Data: NTAGI Chief

Early Covaxin Study Shows Protections Against Beta & Delta Variants Of Covid-19

Lancet Study Suggests Shorter Gap Between Vaccine Doses To Build Antibody Against Delta Variant